Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
CAY10566
Cat. No.:
OB0225LY-0223
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR and HPLC.
Size:
Product Overview
Description:
CAY10566 is a selective tyrosine kinase inhibitor used to study the biological mechanisms of cancer cell proliferation and metastasis.
Synonym:
944808-88-2; 2-(6-(4-(2-Chloro-5-fluorophenoxy)piperidin-1-yl)pyridazin-3-yl)-5-methyl-1,3,4-oxadiazole; 3-[4-(2-Chloro-5-fluorophenoxy)-1-piperidinyl]-6-(5-methyl-1,3,4-oxadiazol-2-yl)-pyridazine; 2-[6-[4-(2-Chloro-5-fluorophenoxy)piperidin-1-yl]pyridazin-3-yl]-5-methyl-1,3,4-oxadiazole; 3-[4-(2-Chloro-5-fluorophenoxy)piperidin-1-yl]-6-(5-methyl-1,3,4-oxadiazol-2-yl)pyridazine
CAS No.:
944808-88-2
Compound CID:
16732433
Formula:
C18H17ClFN5O2
Formula Weight:
389.81
Specification
Relative Density:
1.369 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
CAY10566 can be used for tumor biology research.
Library Information
Targets:
Stearoyl-CoA desaturase (SCD) family
Receptors:
SCD1
Pathways:
Metabolism
Plate Number:
AOCL-3
Plate Location:
g7
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
24 mg/mL; 61.57 mM
